1. Home
  2. FNWD vs FATE Comparison

FNWD vs FATE Comparison

Compare FNWD & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

HOLD

Current Price

$44.65

Market Cap

147.7M

Sector

Finance

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.52

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
FATE
Founded
1994
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.7M
125.6M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
FNWD
FATE
Price
$44.65
$2.52
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$37.50
$4.10
AVG Volume (30 Days)
20.6K
2.7M
Earning Date
04-28-2026
05-14-2026
Dividend Yield
1.51%
N/A
EPS Growth
N/A
29.88
EPS
0.52
N/A
Revenue
N/A
$6,646,000.00
Revenue This Year
$17.40
N/A
Revenue Next Year
$5.44
N/A
P/E Ratio
$85.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.12
$0.91
52 Week High
$45.00
$3.23

Technical Indicators

Market Signals
Indicator
FNWD
FATE
Relative Strength Index (RSI) 81.93 42.33
Support Level $35.02 $1.01
Resistance Level N/A $3.22
Average True Range (ATR) 0.76 0.21
MACD 0.74 -0.09
Stochastic Oscillator 92.00 11.22

Price Performance

Historical Comparison
FNWD
FATE

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: